Medicare

By the Retiree Report Editorial Team · Updated 2026-04-25 · 7 min read

This article is general information, not medical advice. Talk with a licensed clinician before making any decision about your care.

Medicare Part D’s $2,100 cap in 2026: what the new prescription limit really means

If you take expensive prescription drugs, 2026 is the year you stop paying without a ceiling. Medicare Part D now has a hard annual out-of-pocket maximum of $2,100. That’s $100 more than the $2,000 figure many people first heard about, because the Inflation Reduction Act tied the cap to drug-cost inflation starting in 2026. Hit that number on covered medicines, and your share of the cost drops to zero for the rest of the year.

How the 2026 Part D benefit is structured

Medicare Part D works in stages, and the 2026 numbers come straight from the Centers for Medicare & Medicaid Services Final CY 2026 Part D Redesign Program Instructions. First comes the deductible. No Part D plan can charge more than $615 in 2026, though many plans charge less or skip the deductible altogether. You pay the full negotiated price of your covered drugs until you’ve satisfied that deductible.

Next is the initial coverage phase. You pay 25% coinsurance on covered Part D drugs, whether they’re generic or brand name. Your plan picks up the rest. That 25% share continues until your year-to-date out-of-pocket spending reaches $2,100. Once you cross the threshold, you enter the catastrophic phase, and you owe nothing more for covered drugs through December 31. The clock then resets on January 1.

This is a sharp simplification of the old four-stage benefit. The donut hole is gone. So is the 5% coinsurance that used to follow it. According to Medicare.gov, every Part D plan must follow this structure, including stand-alone drug plans (PDPs) and Medicare Advantage plans that include drug coverage (MAPDs).

Where the $2,100 cap came from

The cap originated with the Inflation Reduction Act of 2022, which restructured Part D in stages. KFF’s policy explainer lays out the timeline: in 2024, Congress eliminated the 5% coinsurance above the catastrophic threshold, which effectively held annual out-of-pocket spending around $3,250 that year. Then in 2025, the law replaced that informal ceiling with a true hard cap of $2,000.

That $2,000 figure was never meant to stay frozen. The statute requires CMS to adjust it each year by the percentage increase in average per-enrollee Part D spending. For 2026, that calculation produced $2,100. The maximum deductible moved with it, rising from $590 in 2025 to $615 in 2026. Expect both numbers to keep climbing each year, though the cap should still grow far more slowly than the underlying drug costs would have grown without it.

The federal Office of the Assistant Secretary for Planning and Evaluation projected that roughly 11 million Part D enrollees would reach the spending cap in 2025, with average savings of about $600 per person. People who don’t qualify for the Extra Help low-income subsidy were projected to save closer to $1,100 each. The savings should be similar in 2026, though spread across a slightly higher threshold.

What spending actually counts toward the cap

This is where many beneficiaries get tripped up. Only your out-of-pocket spending on drugs your plan covers counts. That includes the deductible you pay at the start of the year, plus any copays or coinsurance for drugs on your plan’s formulary. The full price of those covered drugs, including the portion paid by manufacturers under the new Coverage Gap Discount Program, does not count toward your $2,100 — only what you personally pay.

A few costs that look like prescription expenses do not count toward the cap:

• Your monthly Part D premium. It’s a separate cost. The cap is a spending ceiling on drugs, not on plan membership.
• Drugs your plan doesn’t cover. If a medication isn’t on the formulary and you pay cash for it, that money doesn’t move you toward the cap.
• Drugs covered under Medicare Part B. That includes most chemotherapy infusions, injectables given in a doctor’s office, and many vaccines billed through Part B. Those have a separate cost-sharing structure.
• Over-the-counter medicines and supplements, even if your doctor recommended them.

If you take a non-formulary drug your physician believes is medically necessary, you can ask the plan for a formulary exception. If approved, the drug is treated as covered, and your cost-sharing for it does count toward the $2,100. The formal request form lives on Medicare.gov, and your prescriber typically has to provide a supporting statement.

The new monthly payment option: how it works

The cap doesn’t change how much you pay over the year. It just sets the ceiling. But hitting that ceiling can still mean a brutal first quarter if a single specialty drug costs $1,500 a month. To address that, CMS rolled out the Medicare Prescription Payment Plan, sometimes called M3P. It lets you spread your covered out-of-pocket costs across the calendar year in monthly installments instead of paying everything at the pharmacy counter.

Here’s the mechanics. You opt in through your Part D or Medicare Advantage drug plan. When you fill a prescription, you pay $0 at the pharmacy for that fill. Your plan then bills you each month. The bill is calculated by taking what you would have owed that month, adding any unpaid balance, and dividing by the months remaining in the year. There’s no interest and no fees, even on a late payment, and your plan must give you at least a two-month grace period before disenrolling you for non-payment.

The math means your monthly bill changes over time. A new high-cost prescription early in the year inflates later installments because there are fewer months to spread the cost across. Someone hitting the full $2,100 cap evenly across 12 months would average about $175 a month, but in practice the bills are usually larger toward year-end if the heavy spending happens up front. CMS finalized automatic renewal for 2026, so anyone who used the plan in 2025 stays enrolled unless they opt out.

This option helps most if you have a single high-cost drug or if you’d otherwise charge prescriptions to a credit card. It helps less, or not at all, if your monthly drug bills are already low and predictable. The plan won’t lower your total annual cost — it just shifts when you pay.

The first negotiated drug prices land in January

Alongside the cap, the Inflation Reduction Act gave Medicare the authority to negotiate prices directly with drugmakers for the first time. The first round of negotiated prices took effect on January 1, 2026, on ten Part D drugs. According to KFF’s negotiation tracker, the list includes Eliquis and Xarelto for blood clots, Jardiance, Januvia, Farxiga, and Fiasp/NovoLog for diabetes, Entresto for heart failure, Stelara and Enbrel for autoimmune conditions, and Imbruvica for blood cancers.

The negotiated prices range from 38% to 79% below 2023 list prices, and CMS estimates beneficiaries collectively saved $1.5 billion. AARP reports that nearly 9 million people take at least one of these ten drugs. If you’re one of them, the lower negotiated price means each fill counts less toward your $2,100 cap, so the cap may not be as easy to reach as it was in 2025. That’s a financial win even if it sounds counterintuitive.

CMS has already selected an additional 15 Part D drugs for negotiation in 2027 and another 15 Part B and Part D drugs for 2028, so this list will keep expanding.

What to do during open enrollment and beyond

The fall Annual Enrollment Period (October 15 to December 7) is the main window to compare Part D plans. Even if you’re happy with your plan, the Medicare Plan Finder at Medicare.gov will tell you which plans cover your specific drugs at the lowest total annual cost given your prescriptions, the new $2,100 cap, and any negotiated prices. Plans change formularies, tiers, and pharmacy networks each year, so a plan that was best for you in 2025 may not be in 2026.

Two practical moves are worth doing today. First, verify that every drug you take is on your current plan’s formulary, because non-formulary spending won’t count toward the cap. Second, if a high-cost drug is forcing big January bills, ask your plan whether you’d benefit from the Medicare Prescription Payment Plan. None of this replaces a conversation with your doctor or pharmacist about whether a generic, biosimilar, or therapeutic alternative would work for you.

What to remember

The 2026 Part D out-of-pocket cap is $2,100, not $2,000 — the original Inflation Reduction Act figure has already been adjusted for drug-cost inflation. The cap covers what you pay for drugs on your plan’s formulary; premiums, non-covered drugs, and most Part B medications don’t count. If a single expensive prescription would empty your bank account in January, the Medicare Prescription Payment Plan can spread your share across the year at no extra cost.